ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 441 filers reported holding ASTRAZENECA PLC in Q3 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,157 | +19.0% | 40,482 | +3.3% | 0.06% | +17.6% |
| Q1 2024 | $2,654 | -2.7% | 39,179 | -3.2% | 0.05% | -10.5% |
| Q4 2023 | $2,727 | +1.4% | 40,494 | +2.4% | 0.06% | -6.6% |
| Q3 2023 | $2,689 | -4.5% | 39,545 | +0.1% | 0.06% | 0.0% |
| Q2 2023 | $2,817 | +7.4% | 39,497 | +4.5% | 0.06% | -1.6% |
| Q1 2023 | $2,622 | +3.0% | 37,788 | +0.6% | 0.06% | -1.6% |
| Q4 2022 | $2,546 | -99.9% | 37,549 | -1.4% | 0.06% | +8.6% |
| Q3 2022 | $2,090,000 | -3.7% | 38,101 | +16.0% | 0.06% | +3.6% |
| Q2 2022 | $2,170,000 | -5.6% | 32,850 | -5.2% | 0.06% | +9.8% |
| Q1 2022 | $2,298,000 | +24.4% | 34,640 | +9.3% | 0.05% | +27.5% |
| Q4 2021 | $1,847,000 | -3.0% | 31,700 | 0.0% | 0.04% | -11.1% |
| Q3 2021 | $1,904,000 | +21.6% | 31,700 | +21.2% | 0.04% | +21.6% |
| Q2 2021 | $1,566,000 | +13.2% | 26,150 | -6.0% | 0.04% | +8.8% |
| Q1 2021 | $1,383,000 | -29.8% | 27,810 | -29.5% | 0.03% | -32.0% |
| Q4 2020 | $1,971,000 | -23.7% | 39,425 | -16.4% | 0.05% | -30.6% |
| Q3 2020 | $2,583,000 | +6.6% | 47,143 | +2.9% | 0.07% | +1.4% |
| Q2 2020 | $2,424,000 | +13.7% | 45,823 | -4.0% | 0.07% | -6.6% |
| Q1 2020 | $2,131,000 | -6.0% | 47,708 | +5.0% | 0.08% | +22.6% |
| Q4 2019 | $2,266,000 | +17.5% | 45,448 | +5.1% | 0.06% | +10.7% |
| Q3 2019 | $1,928,000 | -27.1% | 43,258 | -32.5% | 0.06% | -24.3% |
| Q2 2019 | $2,644,000 | +6.6% | 64,048 | +4.4% | 0.07% | +5.7% |
| Q1 2019 | $2,480,000 | +8.2% | 61,338 | +1.7% | 0.07% | -1.4% |
| Q4 2018 | $2,292,000 | -5.2% | 60,338 | -1.3% | 0.07% | +16.4% |
| Q3 2018 | $2,418,000 | +87.4% | 61,108 | +66.3% | 0.06% | +74.3% |
| Q2 2018 | $1,290,000 | -61.8% | 36,739 | -62.0% | 0.04% | -59.8% |
| Q1 2018 | $3,378,000 | -20.2% | 96,599 | -20.8% | 0.09% | -14.7% |
| Q4 2017 | $4,233,000 | +2.0% | 122,001 | -0.4% | 0.10% | -4.7% |
| Q3 2017 | $4,152,000 | 0.0% | 122,541 | 0.0% | 0.11% | 0.0% |
| Q3 2016 | $4,152,000 | – | 122,541 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
| Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
| Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
| ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
| Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
| Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
| Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
| Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
| Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |